###### Strengths and limitations of this study

-   This is the first prospective cohort study aiming to reveal the risk factors for lack of catch-up growth despite successful surgical repair of cardiac anomalies during infancy.

-   The strengths of this study include its prospective design, large cohort size (expectedly 5000 patients) and comprehensive collection of data.

-   Selection bias and potentially high loss-to-follow-up rate are the limitations of the study.

Introduction {#s1}
============

Congenital heart disease (CHD) accounts for nearly one-third of all major congenital anomalies combined and affects more than 1 million neonates each year globally.[@R1] Owing to CHD-associated pathophysiological changes such as low energy intake, malabsorption, hypermetabolism and sometimes coexisting gastrointestinal malformations, neonates with CHD are at high risk of developing malnutrition during infancy.[@R2] Previous studies have reported that almost half of infants with CHD are stunted and 15% of the patients suffer from moderate-to-severe malnutrition.[@R8]

In addition to significantly improving the long-term survival of neonates, successful surgical treatment of CHD may also deliver an accelerated growth rate, which usually is referred to as catch-up growth.[@R4] However, studies have shown that postoperative catch-up growth was less pronounced or even absent in 15%--50% of patients depending on the study.[@R4] Failure to observe catch-up growth is presumed to be multidimensional and involving multiple patient-related and surgery-related factors but so far remains largely uninvestigated with only two studies where severe malnutrition before surgery, parental height and developmental delay were identified as potentially associated.[@R4]

In this article, we report the design and rationale of a multicentre, prospective cohort study that aims to identify perioperative factors that are associated with the likelihood of successful or unrealised catch-up growth after surgery for major congenital heart defects and to provide insights into the possible mechanisms.

Methods and analysis {#s2}
====================

Patients and public involvement {#s2-1}
-------------------------------

Neither patients nor the public were involved in the design of this study. The findings of this study will be available to the patients and the public once they have been published.

Study design and patient recruitment {#s2-2}
------------------------------------

This is a prospective, multicentre cohort study being carried out at four tertiary medical institutions situated in four provinces across China (see [online supplementary figure](#SP1){ref-type="supplementary-material"}), that is, Guangzhou Women and Children's Medical Center in Guangzhou (GZ, Guangdong Province), the Children's Hospital of Zhejiang University School of Medicine in Hangzhou (HZ, Zhejiang Province), Gansu Provincial Maternity and Child-Care Hospital in Lanzhou (LZ, Gansu Province) and Zhengzhou Cardiovascular Hospital in Zhengzhou (ZZ, Henan Province). All the study centres are tertiary referral hospitals but located in regions with different cultural and socioeconomic characteristics. Selection of the four study centres was mainly based on the standardised surgical treatment of infant CHD across these centres and their representativeness of patients with different socioeconomic backgrounds.
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Patient recruitment for this study commenced in September 2018 and will continue until the year of 2023. The study population from each centre consists of consecutive infants (\<12 months of age) who are admitted with CHD and who will undergo surgical correction. Patients with any of the following characteristics are excluded: (1) have any diagnosed chromosomal diseases (eg, Down syndrome); (2) have any diagnosed metabolic diseases (eg, galactosaemia and hypothyroidism); (3) have a history of gastrointestinal surgery; (4) have conditions that restrict oral feeding (eg, cleft palate); (5) have parents who are illiterate.

Follow-up protocol {#s2-3}
------------------

After CHD surgery, all study participants will be followed for 1 year, during which they are invited to return to the medical centre for detailed medical examinations and anthropometric measurements. These evaluations will take place at 1, 3, 6 and 12 months after surgery. In order to maintain a high follow-up rate, study participants will be contacted regularly by phone and will stay informed of the study's progress by receiving newsletters from the study centres.

Data collection {#s2-4}
---------------

[Table 1](#T1){ref-type="table"} lists the clinical examinations and assessments to be conducted perioperatively and during follow-up. Prior to CHD surgery, detailed information on medical history including CHD-related treatments and medications will be collected. Baseline anthropometric measurements including body weight, recumbent length, head circumference and triceps skin fold will be obtained by trained nurses 1 day before surgery following standardised procedures. Congenital cardiac malformations will be coded using both the International Classification for Diseases 10th version (ICD-10) and the nomenclature adopted by the Society of Thoracic Surgeons (STS) Congenital Heart Surgery Database.[@R19] Likewise, the surgical procedures will be coded using both the ICD ninth verision for Clinical Modification and the STS procedural codes. Grading of the severity of heart failure signs and symptoms will be assessed using the Ross classification method.[@R20] The Alberta Infant Motor Scale[@R21] will be used to measure the patients' motor development and will be obtained by paediatric rehabilitation technicians who have been trained on paediatric neurology. Biochemical tests on blood samples, ECG and echocardiogram will also be performed. Self-administered questionnaires will be used to collect information on demographics, socioeconomics, mother's reproductive history, gestational vitamin and mineral supplementation, and feeding mode before and after surgery.

###### 

Scheduled examinations

                         Perioperative   Follow-up                                  
  ---------------------- --------------- ----------- ------ ----- ----- ----- ----- -----
  Anthropometry\*        ---                         ---†   ---   ---   ---   ---   ---
  Ross classification    ---                                ---   ---   ---   ---   ---
  AIMS                   ---                                      ---   ---   ---   ---
  Biochemical tests‡     ---                                ---   ---   ---   ---   ---
  ECG                    ---                                ---   ---   ---   ---   ---
  Chest X-ray            ---                                ---   ---   ---   ---   ---
  Cardiac ultrasound     ---                                ---   ---   ---   ---   ---
  Aristotle score                        ---                                        
  RACHS-1 score                          ---                                        
  Inotropic score                                    ---                            
  Questionnaire survey   ---                                ---   ---   ---   ---   ---

\*Including body weight, recumbent length, head circumference, upper arm circumference and triceps skin fold.

†Performed to children with cardiac intenstive care unit (CICU) stay ≥5 days.

‡Complete blood count and blood chemistry tests.

AIMS, Alberta Infant Motor Scale; RACHS, risk adjustment in congenital heart surgery.

Determination of outcomes {#s2-5}
-------------------------

The primary outcomes of the present study are the catch-up growth for weight and height after CHD surgery. Catch-up growth can be defined as growth velocity that is above the average level for the child's age and sex after a period of retardation.[@R10] According to this definition, a child who used to have a weight-for-age z-score or height-for-age z-score more than 2 SD below the mean of the healthy reference population is classified as having catch-up growth if he/she has shown an improved z-score that is above the −2 SD cut-off. Besides the improved z-scores, which are relative measures of catch-up growth, we will also consider the absolute decreases in anthropometric deficits, given the fact that absolute anthropometric deficits might become more marked despite improved z-scores because of the continuously increasing SD during childhood.[@R24]

In addition to the anthropometric outcomes, this study will also investigate the fluctuations of important biomedical indicators of malnutrition before and after CHD surgery, including but not limited to albumin, prealbumin, retinol-binding protein, transferrin and N-terminal probrain natriuretic peptide.

Sample size {#s2-6}
-----------

The annual number of infant CHD surgery performed in each study centre is about 500 in GZ, 300 in HZ and 100 in each of ZZ and LZ; therefore, this study is expected to recruit around 5000 patients during the recruitment period (2018--2023). As this study is a primary epidemiological investigation without any predefined statistical hypothesis to test, a priori sample size calculation is unnecessary.[@R26]

Statistical analyses {#s2-7}
--------------------

Perioperative characteristics of the study participants will be described with either arithmetic mean or percentages. The incidence rates of catch-up growth between two adjacent time points and during the entire period of follow-up will be determined. Analysis of variance and χ^2^ test for repeated measures will be used to test for statistically significant differences in continuous and categorical outcomes, respectively.

Patients' z-cores will be calculated using WHO growth charts as the reference. Multivariable Cox regression models will be fitted to identify risk factors associated with the absence of postoperative catch-up growth, with age as the time scale extending from CHD surgery until the presence of catch-up growth, censoring (death/withdrawal/loss of contact), or the end of the follow-up, whichever comes first. [Table 2](#T2){ref-type="table"} shows the factors that we consider might have associations with postoperative catch-up growth and therefore will be examined in the present study. Random effects will be modelled to deal with the fact that patients in the same study centre are likely to share some common characteristics. The models will be extended to handle time-varying factors (eg, laboratory results).

###### 

Factors that will be considered in risk association analysis for postoperative catch-up growth

  ------------------ -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Patient features   Demographics: age, sex, birth order; parent socioeconomic status; gestational age; birth weight and length; intrauterine factors; breast feeding; timing of CHD diagnosis (early: antenatal or predischarge from birth admission; late: postdischarge from birth admission)
  Preoperative       Anthropometric measurements; nutrition support (route, timing, caloric intake and length); formula type; gastrointestinal infection; mechanical ventilation; AIMS; Ross score; non-cardiac congenital abnormality; laboratory results (haemoglobin, total serum protein, albumin, prealbumin, transferrin, retinol-binding protein, C reactive protein); cardiac function (Ross score, echocardiogram, NT-proBNP)
  Surgery            Type of surgery; RACHS-1 score; Aristotle score
  CICU               Nutrition support (route, timing, caloric intake and length); target energy intake; micronutrient supplementation; postoperative nosocomial infection; residual lesion and timing of reintervention; inotropic score, length of mechanical ventilation; length of CICU stay.
  Follow-up          Breast feeding; formula supplementation; micronutrient supplementation; respiratory and gastrointestinal infections; cardiac function (Ross score, echocardiogram, NT-proBNP)
  ------------------ -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

AIMS, Alberta Infant Motor Scale; CHD, congenital heart disease; CICU, cardiac intensive care unit; NT-proBNP, N-terminal probrain natriuretic peptide; RACHS, risk adjustment in congenital heart surgery.

Discussion {#s3}
==========

Malnutrition is prevalent among paediatric patients with CHD.[@R4] Energy metabolism plays a key role in infant growth and disturbed metabolic balance leads to deviation from the normal growth trajectory. Studies have also shown that, for children with CHD, their total and resting energy expenditures normalise in a few weeks after successful repair of the cardiac lesions, resulting in prompt improvement in growth.[@R30]

However, this 'catch-up growth' following CHD surgery only occurs in some patients[@R4] and determinants of catch-up growth have not been established in currently available studies.[@R4] Early surgery was thought to be associated with a better catch-up growth, but existing evidence is conflicting.[@R3] Low parental height was found to be associated with a risk of postoperative malnutrition but only in one study.[@R4]

Many other perioperative factors might also influence postoperative nutritional status and hence deserve detailed examination. Feeding routes (tube vs oral) have been reported to be associated with preoperative nutritional status.[@R34] One study identified hypoplastic left heart syndrome, longer intubation and duration of withholding enteral feeds, and gastro-oesophageal reflux as risk factors for poor feeding among infants with CHD.[@R35] In another study, the extent of growth retardation was greater in cyanotic than in acyanotic patients, while the greatest improvement in growth occurred in patients with isolated valvular pulmonary stenosis,[@R36] suggesting that nutritional outcomes after surgical intervention might vary by underlying cardiac malformations.

To the best of our knowledge, the present study is the first prospective cohort designed for a thorough investigation of perioperative factors that are associated with persistent growth deficits after infant CHD surgery. This study will provide a good opportunity to assess a wide range of perioperative predictors that have never been examined before. The multicentre design will contribute to a more heterogeneous study population, which improves the generalisability of the results. The prospective nature of this study will help reduce selection bias and improve data quality, compared with retrospective studies. The present study has several limitations including a relatively short duration of follow-up and potentially high rate of loss to follow-up. One year follow-up may limit the assessment of catch-up growth in height, which can require more than 1 year. Because all the participating centres are tertiary referral hospitals, it is likely that a considerable number of study participants do not live nearby the study centres, and some of them will be unwilling to travel a long way back for follow-up examinations.

In summary, given that lack of catch-up growth is relatively common among infants after surgical repair of congenital cardiac anomalies and contributing factors have not been well elucidated, we believe that this prospective study will yield useful information for risk stratification and to identify potential causal mechanisms.

Supplementary Material
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